A Phase I/II Trial of Hydroxychloroquine in Conjunction with Radiation Therapy and Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (Therapeutics Studies of Anaplastic Glioma)

Grant

Date/time Interval

  • February 7, 2011 - December 31, 2019
  • Total Award Amount

  • 3000.00
  • Direct Costs

  • 2381.00
  • Sponsor Award Id

  • NABTT0603
  • Contributor

  • Nabors M.D., Louis   Principal Investigator